Prevailing literature suggests diversified cellular functions for the adenomatous polyposis coli (APC) gene. Among them a recently discovered unique role of APC is in DNA repair. The APC gene can modulate the base excision repair (BER) pathway through an interaction with DNA polymerase β (Pol-β) and flap endonuclease 1 (Fen-1). Taken together with the transcriptional activation of APC gene by alkylating agents and modulation of BER activity, APC may play an important role in carcinogenesis and chemotherapy by determining whether cells with DNA damage survive or undergo apoptosis. In this review, we summarize the evidence supporting this novel concept and suggest that these results will have implications for the development of more effective strategies for chemoprevention, prognosis, and chemotherapy of certain types of tumors.
Introduction
APC is expressed constitutively within the normal colonic epithelium. The APC gene product is a 310-kDa-homodimeric protein, which is localized in the cytoplasm and the nucleus [1] , [2] , [3] , [4] , [5] , [6] and [7] . Appropriate levels of wild-type APC are critical to cytoskeletal integrity [1] and [8] , cellular adhesion [9] , and Wingless/Wnt signaling [7] , [10] and [11] . Wild-type APC binds to EB1, which regulates microtubule polymerization [12] , and a tumor suppressor protein, DLG, which regulates cell cycle progression from the G o /G 1 to the S phase of the cell cycle [13] . Truncation in APC dominantly interferes with mitotic spindle function by regulating microtubule dynamics during mitosis [14] and [15] . In addition, APC may act as a negative regulator of β-catenin signaling in the transformation of colonic epithelial cells [16] and [17] and in melanoma progression [18] . The β-catenin/Tcf4 complex regulates the proto-oncogene and cell cycle regulator c-myc [19] , the G 1 /S-regulating cyclin D1 [20] , the gene encoding the matrix-degrading metalloproteinase, matrilysin [21] , the AP-1 transcription factors c-jun and fra-1 and the urokinase-type plasminogen activator receptor gene [22] . There is a considerable body of evidence that indicates that mutations of APC are associated with colorectal cancer. As described by Muto et al. [23] , colorectal cancer develops through a series of histologically distinct stages from "adenoma to carcinoma" and it has been suggested that this progression through the histologic stages is associated with the temporal order in which mutations occur in different genes [24] and [25] . Mutations in APC, as well as Ki-ras, deleted in colorectal cancer (DCC), and p53 genes all play important roles in the development of colorectal cancer and appear to act at different stages of tumorigenesis [7] and [11] . Mutation of the APC gene is an early event in familial adenomatous polyposis (FAP), a syndrome in which there is an inherited predisposition to colon cancer [26] and [27] . Mutations in the APC gene are also found in 60 to 80% of sporadic colorectal cancers and adenomas [26] , [28] and [29] .
The site of the mutation of the APC gene appears to be of importance in the development of the colorectal cancer. An association has been shown between the severe polyposis phenotype and germline mutations in the mutation cluster region (MCR) of the APC gene [30] , [31] and [32] . Recently, the biological significance of nonsense and frame-shift mutations in MCR has been correlated with truncated and nonfunctional APC protein. Allelic loss of APC gene results in the complete loss of its function. The truncating mutation at nucleotide 3920, identified by in vitro synthesized protein method, converts isoleucine to lysine at codon 1307(I1307K) [33] . This germ-line mutation causes structural abnormalities that impair its biological activity. Selective pressure for an MCR mutant has been proposed based on the germline mutation in familial adenomatous polyposis [34] . Patients with mutations outside of the MCR region exhibit milder phenotypes. A recent study has shown that animals with homozygous truncating mutations at codon 1638 of APC do not develop tumors and survive through adulthood [35] . These data suggest that a truncation mutation in MCR is necessary for the loss of β-catenin binding and nuclear localization signals, resulting in loss of function and tumor progression [36] . It is now established that mutations in APC may be necessary for the early onset of polyposis.
Regulation of the APC gene in response to DNA alkylating agents
Earlier it has been reported that the APC gene is inducible, and its transcription can be enhanced in response to DNA-alkylating agents such as N-methyl-N'-nitro-N-nitrosoguanidine (MNNG), methylmethane sulfonate (MMS) and dimethylhydrazine (DMH) [37] . The promoter region of the APC gene which is fully characterized for various cis-regulatory elements, has a TATA-less promoter and two p53-binding elements, as well as consensus binding sites for Octamer, AP2, Sp1, a CAAT-box, and three nucleotide sequences for E-Box A, B and M [38] . Subsequent studies to understand the mechanism of APC gene regulation suggest that its regulation in response to DNA-alkylating agents can occur through several different mechanisms. Notably, DNA alkylation-induced transcriptional regulation of the APC gene expression in colon cancer cells is mediated through p53-binding elements [39] . This finding was the first evidence of a direct link between p53 and APC. However, overexpression of the upstream stimulating factors 1 and 2 (USF-1 and USF-2) in colon cancer cells that bind to the E-box B site can also upregulate the transcription of the APC gene [38] . The DNA damage-induced APC gene regulation was further supported by another study in which a cigarette smoke constituent, 7,12-dimethyl benzanthracene (DMBA), was shown to upregulate the expression of this gene in spontaneously immortalized normal human breast epithelial cells. In these cells, the DMBA-response on the APC gene expression was mediated through the GC-box binding protein Sp3 [40] . These studies provide clear evidence that DNA alkylation damage can result in enhanced transcription of APC and that this effect can be mediated by various mechanisms. Thus, p53, E Box B and GC-box-binding proteins can upregulate the APC gene expression. However, the involvement of additional mechanisms cannot be ruled out.
Role of APC in base-excision repair
Exogenous and endogenous mutagenic agents attack the genomes of all living cells resulting in the generation of damaged DNA bases. These damaged DNA bases may be cytotoxic and/ or miscoding and are thought to be a major source of intermediates in carcinogenesis and tumorigenesis [41] . DNA repair systems efficiently remove damaged DNA via several different pathways, which reverse the vast majority of genetic lesions formed during the life span of a cell [42] . Base excision repair (BER) is the main pathway for the repair of endogenous abasic DNA damage. Most DNA repair mechanisms, including the base excision repair (BER) pathway, involve the participation of enzymes and other proteins that recognize structural alterations in DNA [43] , [44] and [45] . It has been estimated that approximately one million abasic sites are generated per mammalian cell per day [46] . Abasic sites are unstable and degrade spontaneously into DNA-strand breaks by β-elimination that retards DNA polymerases. The abasic sites are highly mutagenic because they result in non-template DNA and RNA synthesis. Despite the large number of abasic sites generated per cell per day, the number of mutations is extremely low. This discordance underscores the importance of the elaborate mechanisms that the cell has devised to repair abasic sites.
In mammalian cells, BER can proceed through at least two pathways designated as the "single nucleotide (SN)-BER" and "multinucleotide or long-patch (LP)-BER" pathways ( Fig. 1 ). These two pathways are differentiated by the repair patch size, as well as by the contribution of different proteins to the pathway [47] and [48] . In both pathways, repair is initiated by the recognition and removal of the modified base by a DNA glycosylase generating an abasic site (AP-site). Subsequently, APE-1 cleaves the DNA backbone generating 3′-OH and 5'-deoxyribose phosphate (5′-dRP) ends [49] , [50] and [51] . Subsequently, the remaining 5′-dRP residue is cleaved by a 5'-deoxyribose phosphate lyase (dRP-lyase) activity of Pol-β to yield a 5'-phosphorylated gapped-DNA strand [52] . Pol-β then incorporates the correct base at the site of the damaged base with its polymerizing activity and DNA ligase-I or III sealing the nick [53] and [54] . This repair process becomes more complicated once the AP-site becomes oxidized or reduced. Under these circumstances, the dRP-lyase activity of Pol-β is interrupted, and the repair of DNA is accomplished through LP-BER. The Pol-β-dependent stranddisplacement synthesis generates a longer repair patch and a 5'-overhang of a single-stranded DNA-flap with a modified sugar at its 5'-end. Pol-β can also be replaced by Pol-δ/ε for stranddisplacement synthesis [55] . The 5'-overhang DNA-flap is cleaved by flap endonuclease 1 (Fen-1), and finally the nick is sealed by DNA ligase I or III [42] , [47] , [56] , [57] , [58] , [59] and [60] . The reduced activity of any one of the BER proteins either due to reduced expression or interaction with other proteins can lead to decrease in BER. In many colon and lung tumors and cell lines, a defective BER is associated with the development of these cancers [61] , [62] , [63] and [64] .
APC interacts with Pol-β and Fen-1
The role of APC in DNA repair, particularly in base excision repair (BER) pathway is a novel finding, which was initially discovered by determining its interaction with proliferating cell nuclear antigen (PCNA). Since PCNA is known to participate in BER as a cofactor and to stimulate its activity [65] , it was presumed a possibility that the interaction of APC with PCNA may block BER; however, the later studies concluded that the interaction of APC with PCNA did not affect BER. Concomitantly, the possible interaction of APC with other BER proteins such as Pol-β and flap endonuclease 1 (Fen-1), the two key enzymes of the BER pathway, were identified ( Fig. 1) [66] , [67] , [68] and [69] .
APC blocks Pol-β-directed SN-and LP-BER
The dRP-lyase activity of Pol-β is a rate-limiting step in SN-BER [70] and [71] . Biochemical [72] , [73] and [74] and crystallographic studies [75] indicate that Lys72 plays a critical role in the dRP-lyase reaction mechanism. This reaction proceeds via a Schiff-base intermediate between Pol-β and the 5'-dRP residue of the substrate, whereby the side chain of Lys72 provides the nucleophile for the completion of the reaction [76] . By modeling analysis it has indicated that the interaction of APC with Pol-β is mediated by a stretch of residues near Lys72 (Fig. 3) [71] . The crystal structure of Pol-β indicates that Lys35, Lys68, Lys72 and Lys84 coordinate the 5'-phosphate of a gapped-DNA and may modulate its dRP-lyase activity [77] . Since the interaction of APC with Thr79, Lys81 and Arg83 falls near the dRP-lyase active site pocket, the influence of APC binding on dRP-lyase activity has been examined. The interaction of APC's DRI-domain with amino acid residues Thr79, Lys81 and Arg83 of Pol-β blocked Pol-β-directed dRP-lyase activity [68] . The mechanism of blockage of LP-BER by APC is more complex than the blockage of SN-BER [68] . In LP-BER, APC interacts with Pol-β and blocks Pol-β-directed strand-displacement synthesis. It also interacts with Fen-1 and blocks its 5'-flap endonuclease and 3'-5' exonuclease activities [67] . Thus, by blocking both activities of Pol-β as well as Fen-1, APC blocks LP-BER [68] . Currently, the precise consequence of the blocked SN-and LP-BER on cellular fate is not clear.
Physiological significance of the APC-mediated blockage of SN-and LP-BER activities
Most mutations of the APC gene occur in the MCR region and result in the production of a truncated protein. This truncation of the protein compromises several functions of APC and contributes to chromosomal instability [78] and [79] . Whether APC-mediated blockage of SNand LP-BER pathways has any physiological consequence in development of colorectal cancer is not yet examined. The DRI-domain of APC, which is the site of interaction with Pol-β and Fen-1, is located in the N-terminal region and is spared by mutations of MCR that result in truncation of the protein. Thus, most mutant APC proteins (those with an intact DRI-domain), as well as wild-type APC, are capable of modulating BER (Fig. 2) .
Earlier studies have indicated that DNA-alkylating agents can enhance the level of APC in colorectal cancer cells. The induced level of APC thus can block SN-and LP-BER activities and affect cellular responses. Depending upon the cellular context and the extent of DNA damage, the consequence of APC/BER interaction could lead to either enhanced alkylationinduced carcinogenesis or apoptosis (Fig. 4) . The former scenario is indicated by our studies of the effects of cigarette smoke condensate (CSC), a surrogate for cigarette smoke, which induces APC gene expression. We have found that the enhanced levels of APC block LP-BER and that this might contribute to the transformation of spontaneously immortalized normal breast epithelial cells [80] . On the other hand, treatment with methylmethane sulfonate (MMS) increases APC levels, blocks BER and induces apoptosis in human colon cancer cell lines and mouse embryonic fibroblast cells [66] and [81] . Collectively, the results of these studies suggest a previously unrecognized function of APC as a pivotal determinant of the fate of a cell with damaged DNA. The role of APC in carcinogenesis is paradoxical; however, its role in apoptosis supports tumor suppressor function which needs to be further ascertained in future studies.
Concluding remarks
The studies discussed in this review are critical for understanding the mechanisms that define whether a cell that has sustained DNA damage survives and enters into the carcinogenic cascade or whether it becomes apoptotic. The current understanding is that the type and level of DNA damage plays a critical role in defining the outcome. That is, in response to DNA damage, the cells can adequately repair the damage and survive with no apparent consequence to the organism as a whole. When a threshold limit of DNA damage is incurred, the cell tries to repair the damage; however, according to the currently accepted understanding, a few cells may escape the repair, acquire additional cell survival characteristics, and become tumorigenic. If the extent of DNA damage sustained is higher than the repair capacity, the cell becomes apoptotic. Thus, in those cells that has DNA damage above the threshold limit, the APC level increases and blocks Pol-β-directed BER leading to apoptosis (Fig. 4) . In summary, since APC plays a central role in the development of colon cancer, a fuller understanding of its novel role in DNA repair mechanisms will provide valuable information for more effective prognosis and treatment of colon cancers without affecting normal colonic epithelial cells. The 2843 amino acid sequence displays an armadillo domain near the N-terminus. There are two β-catenin binding domains. The first 15-amino acid repeat can bind β-catenin, but its functional significance is still obscure, while the 20-amino acid repeat can bind β-catenin with a high affinity upon phosphorylation. The DRI-domain, just upstream of MCR, is involved in the regulation of the BER pathway. Asef, APC-stimulated guanine nucleotide exchange factor; DLG, Drosophila discs large; EB1, end-binding protein 1, KAP3A, kinesin superfamilyassociated protein 3A; NES, nuclear export signal; NLS, nuclear localization signal; PP2-B56α, protein phosphatase 2A B56α subunit. , we found the interaction domain of Pol-β with APC located within the stretch of amino acid residues 80−120. To further identify critical residues of Pol-β that might be involved in the interaction with APC, the solvent surface accessibility of residues suspected from the yeast two-hybrid analysis to interact with APC was examined. Since the crystal structure of APC has not been solved, it is not feasible to identify probable interactions through possible docking modes. The crystal structure of a substrate complex of Pol-β indicates that it is composed of two-domains with distinct enzymatic activities necessary for SN-BER: an amino-terminal lyase domain and a carboxyl-terminal polymerase domain. Residues suspected of interacting with APC are in a stretch of amino acids 80−120 that connect these domains. From the structure of the ternary substrate complex, two regions -Set-1 (amino acid Thr79, Lys81 and Arg83) and Set-2 (amino acid Arg89, Gln90 and Asp92) -are identified that exhibit high solvent accessibility. The protein backbone of Set-1 region can be seen in the structure. Alteration of the backbone dynamics of this region is expected to affect Pol-β-dependent substrate binding and/or catalysis. Set-1 residues are displayed on a ribbon representation of a ternary substrate complex of Pol-β (pdb accession code 2FMS). The lyase and polymerase domains are colored yellowish green and blue, respectively, and the DNA backbone is red and pink. Site-directed mutagenesis studies suggested that Set-1 amino acid residues (Thr79, Lys81 and Arg83) are important for the interaction with APC.
Fig. 4.
A hypothetical model for the role of APC blockage of BER in carcinogenesis and chemotherapy.
